LOVELAND, Colo., Sept. 29, 2016 /PRNewswire/ -- Heska
Corporation (NASDAQ: HSKA) (News; "Heska" or the "Company"),
a provider of veterinary diagnostic and specialty products, today
reported several key executive promotions as part of its ongoing
growth initiatives. Mr. John McMahon
is promoted to Chief Financial Officer. Mr. Jason Napolitano continues as Chief Operating
Officer and adds the role of Chief Strategist. Mr. Steve Eyl is promoted to Executive Vice
President, Global Sales and Marketing. All three executives will
report to Mr. Kevin Wilson, Heska's
Chief Executive Officer and President. Nancy Wisnewski, PhD, was named Executive Vice
President, Diagnostic Operations & Product Development,
reporting to Mr. Napolitano.
"For the past three years, Heska has grown revenues and
profitability at a rapid pace, in a healthy manner, while capturing
market share and establishing a broad base of customers to drive
long-term recurring revenue," said Kevin
Wilson. "Today, we are augmenting and reorganizing our
leadership team to leverage this success and solidify Heska's
position. As we take our next major growth steps in business
development, product development, geographic expansion, and market
share, we also continue to execute our plans for expanding talent
and team excellence with today's promotions."
John McMahon, Chief Financial
Officer.
John McMahon,
CPA is promoted to be the Company's Chief Financial Officer. Mr.
McMahon, aged 51, was appointed Vice President, Financial
Operations & Controller in October of 2015. Over the past year
Mr. McMahon has worked well and closely with Mr. Napolitano, CFO,
COO and the Audit Committee of the Company's board of
directors.
Bonnie Trowbridge, Chairperson of
the Company's Audit Committee, commented, "John has the
demonstrated expertise, ethics, and leadership that reaffirms our
initial confidence in his selection as a key member of Heska's
team. We are excited to promote him to his new role as Heska's
Chief Financial Officer."
Mr. Wilson, Heska's CEO and President added, "John has proven
himself more than ready for the larger role I anticipated for him
when we first began work together last year. I am excited to
announce his promotion today."
Jason Napolitano, Chief
Operating Officer, Chief Strategist.
Jason Napolitano has been Heska's Chief
Financial Officer and Executive Vice President since 2002. In
preparation of today's announcement to strengthen and broaden
Heska's executive team, Mr. Napolitano was made the Company's Chief
Operating Officer in October of 2015. With today's promotion, Mr.
Napolitano will continue in his role of Chief Operating Officer and
will today also assume the role of Chief Strategist. From 1990 to
2001, Mr. Napolitano held various positions at Credit Suisse First
Boston, an investment bank, including Vice President in health care
investment banking and Director in mergers and acquisitions. He
holds a B.S. degree from Yale
University.
"Jason's deep and longstanding understanding of Heska's
business, combined with his sharp intelligence and strong work
ethic make him a cornerstone member of our team," said Kevin Wilson, the Company's CEO and President.
"In his new role as Chief Strategist, I am excited to work closely
with Jason to develop Heska's significant opportunities within the
global veterinary healthcare space. Because Jason understands the
fine details and the broad trends within Heska, the veterinary
diagnostics market, and the health care mergers and acquisitions
space, he is uniquely qualified to help Heska reach a much larger
role within the veterinary healthcare industry."
Steve Eyl, Executive Vice
President, Global Sales and Marketing.
Steve Eyl is promoted to be the Company's
Executive Vice President, Global Sales and Marketing. Mr. Eyl has
been Heska's Executive Vice President, Commercial Operations since
May 2013. Mr. Eyl was President of
Sound Technologies, Inc. ("Sound") from 2000 to 2011, including
after Sound's acquisition by VCA Antech, Inc. in 2004.
"I have known and trusted Steve since our days together at Sound
beginning in 2000," added Mr. Wilson. "Steve joined Heska in May of
2013 with a clear goal: to make Heska's commercial teams excellent.
By any measure it is clear that he has done a fantastic job. As we
expand our efforts to international markets, expand our business
development activities, and broaden our product offerings, I am
confident that Steve's leadership, judgment and winning
expectations will carry the day for Heska."
Nancy Wisnewski, PhD,
Executive Vice President Diagnostic Operations & Product
Development.
Dr. Wisnewski is promoted to Executive
Vice President Diagnostic Operations & Product Development.
Mr. Wilson added, "Nancy has done a fantastic job for Heska
since 1993. As we continue to grow, it is important to frame key
roles and responsibilities more precisely. Nancy's contributions to
Heska's success are innumerable. With this promotion, I am pleased
to highlight her critical role in making Heska the leader in
operations and quality in the veterinary diagnostics space. As we
expand further, continuing this excellence is key to our
plans."
Dr. Wisnewski was appointed Executive Vice President,
Product Development and Customer Support in April 2011. She served as Vice President, Product
Development and Technical Customer Service from December 2006 to April
2011. From January 2006 to
November 2006, Dr. Wisnewski was Vice
President, Research and Development. Dr. Wisnewski holds a Ph.D. in
Parasitology/Biochemistry from the University
of Notre Dame and a B.S. in Biology from Lafayette College.
About Heska
Heska Corporation (NASDAQ: HSKA -
News) sells advanced veterinary diagnostic and specialty products.
Heska's state-of-the-art offerings include blood testing
instruments and supplies, digital imaging products, software and
services, data services, allergy testing and immunotherapy, and
single-use offerings such as in-clinic diagnostic tests and
heartworm preventive products. The Company's core focus is on the
canine and feline markets where it strives to provide high value
products and unparalleled support to veterinarians. For further
information on Heska and its products, visit www.heska.com.
Forward-Looking Statements
This announcement
contains forward-looking statements. These statements are based on
current expectations and are subject to a number of risks and
uncertainties. Factors that could affect the business and financial
results of Heska generally include, but are not limited to, the
following: uncertainties related to Heska's ability to measure and
predict trends in the veterinary market; uncertainties related to
Heska's ability to measure and predict the effectiveness of
personnel and commercial relationships; uncertainties related to
the future impact of recent business development activity; risks
related to Heska's reliance on third-party suppliers, which is
substantial; competition; and the risks set forth in Heska's
filings and future filings with the Securities and Exchange
Commission, including those set forth in Heska's Quarterly Report
on Form 10-Q for the three months ended June
30, 2016.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/heska-announces-executive-promotions-to-further-growth-initiatives-300336916.html
SOURCE Heska Corporation